Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Genitourinary 2 Thoracic 1 Myeloid 1 Gastrointestinal 1 Dermatologic 1

Conditions

Osteoporosis 1 Mastocytosis, Systemic 1

Interventions

fludarabine 30 Specimen Handling 28 Cyclophosphamide 27 Azacitidine 23 venetoclax 22 fludarabine phosphate 22 Biopsy 22 ruxolitinib 18 Whole-Body Irradiation 17 Cytarabine 17 Mycophenolic Acid 16 Busulfan 16 asciminib 15 Tacrolimus 15 Melphalan 14 Injections 12 Decitabine 12 decitabine and cedazuridine drug combination 11 X-Rays 11 Magnetic Resonance Spectroscopy 11 Stem Cell Transplantation 10 Granulocyte Colony-Stimulating Factor 10 Sirolimus 9 Peripheral Blood Stem Cell Transplantation 9 Cyclosporine 9 Thiotepa 8 Filgrastim 8 nilotinib 7 Imatinib Mesylate 7 Phantoms, Imaging 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Denosumab × Myeloid × 90 days × Clear all

NCT03401060 2026-03-31

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡